$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000072137117000031 Filed on May 02, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$32.97B	$31.82B	$30.66B
YoY Change	5.04%	3.78%	20.84%
Cost Of Revenue	$31.34B	$30.09B	$28.97B
YoY Change	5.47%	3.87%	21.14%
Gross Profit	$1.623B	$1.728B	$1.689B
YoY Change	-2.52%	2.31%	15.76%
Gross Profit Margin	4.92%	5.43%	5.51%
Selling, General & Admin	$983.0M	$960.0M	$914.0M
YoY Change	1.34%	5.03%	13.82%
% of Gross Profit	60.57%	55.56%	54.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$192.0M	$186.0M	$159.0M
YoY Change	9.09%	16.98%	37.07%
% of Gross Profit	11.83%	10.76%	9.41%
Operating Expenses	$983.0M	$960.0M	$914.0M
YoY Change	1.34%	5.03%	13.82%
Operating Profit	$640.0M	$605.0M	$656.0M
YoY Change	-7.91%	-7.77%	11.0%
Interest Expense	-$67.00M	$46.00M	$44.00M
YoY Change	52.27%	4.55%	25.71%
% of Operating Profit	-10.47%	7.6%	6.71%
Other Income/Expense, Net	$3.000M	$5.000M	$0.00
YoY Change			-100.0%
Pretax Income	$375.0M	$564.0M	$612.0M
YoY Change	-34.9%	-7.84%	9.68%
Income Tax	$97.00M	$182.0M	$226.0M
% Of Pretax Income	25.87%	32.27%	36.93%
Net Earnings	$274.0M	$381.0M	$386.0M
YoY Change	-17.72%	-1.3%	5.75%
Net Earnings / Revenue	0.83%	1.2%	1.26%
Basic Earnings Per Share			$1.18
Diluted Earnings Per Share	$856.3K	$1.198M	$1.17
COMMON SHARES
Basic Shares Outstanding	315.9M shares	316.0M shares	328.0M shares
Diluted Shares Outstanding		318.0M shares	331.0M shares

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.879B	$1.368B	$2.598B
YoY Change	191.98%	-47.34%	-18.38%
Cash & Equivalents	$6.879B	$1.368B	$2.598B
Short-Term Investments
Other Short-Term Assets	$2.117B	$1.769B	$1.491B
YoY Change	33.99%	18.65%	25.29%
Inventory	$11.30B	$11.64B	$10.91B
Prepaid Expenses
Receivables	$8.048B	$7.505B	$7.292B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.35B	$22.28B	$22.29B
YoY Change	29.1%	-0.04%	13.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.879B	$1.849B	$1.683B
YoY Change	4.62%	9.86%	19.62%
Goodwill	$7.221B	$7.209B	$6.888B
YoY Change	0.75%	4.66%	36.26%
Intangibles	$1.986B	$2.078B	$2.262B
YoY Change	0.0%	-8.13%	131.29%
Long-Term Investments
YoY Change
Other Assets	$681.0M	$755.0M	$931.0M
YoY Change	-27.86%	-18.9%	13.95%
Total Long-Term Assets	$11.77B	$11.89B	$11.76B
YoY Change	-3.28%	1.08%	42.47%
TOTAL ASSETS
Total Short-Term Assets	$28.35B	$22.28B	$22.29B
Total Long-Term Assets	$11.77B	$11.89B	$11.76B
Total Assets	$40.11B	$34.17B	$34.06B
YoY Change	17.55%	0.35%	22.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.91B	$17.54B	$17.34B
YoY Change	3.47%	1.12%	25.19%
Accrued Expenses	$1.988B	$1.654B	$1.694B
YoY Change	9.96%	-2.36%	-25.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.327B	$607.0M	$351.0M
YoY Change	126.06%	72.93%	24.03%
Total Short-Term Liabilities	$21.22B	$19.80B	$19.39B
YoY Change	7.72%	2.12%	18.24%
LONG-TERM LIABILITIES
Long-Term Debt	$9.068B	$4.854B	$5.195B
YoY Change	83.12%	-6.56%	39.65%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$9.068B	$4.854B	$5.195B
YoY Change	83.12%	-6.56%	39.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.22B	$19.80B	$19.39B
Total Long-Term Liabilities	$9.068B	$4.854B	$5.195B
Total Liabilities	$33.30B	$27.53B	$27.34B
YoY Change	20.81%	0.68%	27.06%
SHAREHOLDERS EQUITY
Retained Earnings	$4.967B	$4.842B	$6.231B
YoY Change	-22.62%	-22.29%	16.4%
Common Stock	$2.697B	$2.684B	$2.995B
YoY Change	-10.4%	-10.38%	0.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$731.0M	$744.0M	$2.429B
YoY Change	-73.5%	-69.37%	26.31%
Treasury Stock Shares	11.00M shares	11.00M shares	38.00M shares
Shareholders Equity	$6.808B	$6.646B	$6.713B
YoY Change
Total Liabilities & Shareholders Equity	$40.11B	$34.17B	$34.06B
YoY Change	17.55%	0.35%	22.11%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$274.0M	$381.0M	$386.0M
YoY Change	-17.72%	-1.3%	5.75%
Depreciation, Depletion And Amortization	$192.0M	$186.0M	$159.0M
YoY Change	9.09%	16.98%	37.07%
Cash From Operating Activities	$724.0M	-$198.0M	$919.0M
YoY Change	12.95%	-121.55%	39.67%
INVESTING ACTIVITIES
Capital Expenditures	-$94.00M	-$80.00M	-$109.0M
YoY Change	-48.07%	-26.61%	94.64%
Acquisitions
YoY Change
Other Investing Activities	$118.0M	-$112.0M	-$101.0M
YoY Change	-154.13%	10.89%	-56.09%
Cash From Investing Activities	$24.00M	-$192.0M	-$210.0M
YoY Change	-106.02%	-8.57%	-26.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.760B	-128.0M	-438.0M
YoY Change	-1093.74%	-70.78%	525.71%
NET CHANGE
Cash From Operating Activities	724.0M	-198.0M	919.0M
Cash From Investing Activities	24.00M	-192.0M	-210.0M
Cash From Financing Activities	4.760B	-128.0M	-438.0M
Net Change In Cash	5.508B	-518.0M	271.0M
YoY Change	-2424.05%	-291.14%	-10.26%
FREE CASH FLOW
Cash From Operating Activities	$724.0M	-$198.0M	$919.0M
Capital Expenditures	-$94.00M	-$80.00M	-$109.0M
Free Cash Flow	$818.0M	-$118.0M	$1.028B
YoY Change	-0.49%	-111.48%	43.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000000	USD
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	cah	Accrued Litigation Charges Net AccruedLitigationChargesNet	93000000	USD
CY2016Q1	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	108000000	USD
	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	327000000	USD
CY2017Q1	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	128000000	USD
	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	365000000	USD
CY2016Q1	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	0	USD
	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	8000000	USD
CY2017Q1	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	1000000	USD
	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	4000000	USD
	cah	Increase Decrease In Dollar Amount Of Common Sharesin Treasury From Retirement Of Shares IncreaseDecreaseInDollarAmountOfCommonSharesinTreasuryFromRetirementOfShares	-2500000000	USD
	cah	Increase Decrease In Retained Earnings From Retirement Of Shares IncreaseDecreaseInRetainedEarningsFromRetirementOfShares	-2200000000	USD
	cah	Increase Decreasein Common Shares Amount From Retirementof Shares IncreaseDecreaseinCommonSharesAmountFromRetirementofShares	-302000000	USD
CY2016Q2	cah	Indemnification Receivable IndemnificationReceivable	172000000	USD
CY2017Q1	cah	Indemnification Receivable IndemnificationReceivable	140000000	USD
	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-3000000	USD
	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	20000000	USD
	cah	Paymentof Contingent Consideration PaymentofContingentConsideration	23000000	USD
	cah	Paymentof Contingent Consideration PaymentofContingentConsideration	3000000	USD
	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	0	USD
	cah	Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets	1000000	USD
	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	99000000	USD
	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	115000000	USD
CY2016Q1	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	9000000	USD
	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	20000000	USD
CY2017Q1	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	2000000	USD
	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	4000000	USD
	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	150000000	USD
	cah	Purchaseofavailableforsalesecuritiesandotherinvestments Purchaseofavailableforsalesecuritiesandotherinvestments	188000000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000721371
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	315882555	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CARDINAL HEALTH INC
	dei	Trading Symbol TradingSymbol	cah
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17306000000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17535000000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-116000000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-136000000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82000000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	73000000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	88000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	255000000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	96000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	291000000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000	shares
CY2016Q2	us-gaap	Assets Assets	34122000000	USD
CY2017Q1	us-gaap	Assets Assets	34174000000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	21956000000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	22283000000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	200000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	113000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	128000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	87000000	USD
CY2017Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	69000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-16000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4616000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2598000000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2356000000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1368000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2018000000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-988000000	USD
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.3870
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.1610
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4489
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.3467
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	3010000000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	2684000000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	399000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1034000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	416000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	994000000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2000000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	399000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1035000000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	417000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	996000000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	28973000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	85285000000	USD
CY2017Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	30093000000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	92089000000	USD
CY2016Q2	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	5539000000	USD
CY2017Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	5461000000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	29000000	USD
CY2016Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2781000000	USD
CY2017Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2742000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	465000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	525000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-7000000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-5000000	USD
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.369
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.355
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.323
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.344
CY2016Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	9000000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	28000000	USD
CY2017Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	9000000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	25000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	33000000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	37000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1075000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1362000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	98000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	214000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	264000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	294000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	363000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3262000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3369000000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2187000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2007000000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P10Y
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4000000	USD
CY2016Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	USD
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-17000000	USD
CY2017Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-2000000	USD
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-15000000	USD
CY2016Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-5000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	3000000	USD
CY2017Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-18000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-37000000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	7167000000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	7209000000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	57000000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	15000000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	1689000000	USD
	us-gaap	Gross Profit GrossProfit	4877000000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	1728000000	USD
	us-gaap	Gross Profit GrossProfit	4921000000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	612000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1700000000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	564000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1549000000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.18
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.33
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.21
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.19
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.17
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	3.30
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	1.20
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	3.17
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	226000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	604000000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	182000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	533000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2839000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	225000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1457000000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1010000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26000000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	327000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	721000000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	107000000	USD
CY2016Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	72000000	USD
CY2017Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	71000000	USD
CY2016Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3334000000	USD
CY2017Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3440000000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2259000000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2078000000	USD
CY2016Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9426000000	USD
CY2017Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9287000000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	44000000	USD
	us-gaap	Interest Expense InterestExpense	134000000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	46000000	USD
	us-gaap	Interest Expense InterestExpense	134000000	USD
CY2016Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	12000000	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	51000000	USD
CY2017Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-9000000	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	0	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	10615000000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	11641000000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34122000000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34174000000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	19701000000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	19796000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4952000000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	4854000000	USD
CY2016Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	587000000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	607000000	USD
CY2016Q2	us-gaap	Minority Interest MinorityInterest	17000000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	19000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-660000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1014000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3681000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-429000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2330000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	460000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	386000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1095000000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	381000000	USD
	us-gaap	Net Income Loss NetIncomeLoss	1014000000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	USD
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	656000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1839000000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	605000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1681000000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1808000000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1654000000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1580000000	USD
CY2017Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1769000000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	944000000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	755000000	USD
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-23000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-3000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-4000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	27000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-57000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	33000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-47000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	13000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-61000000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	35000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-20000000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	USD
	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	0	USD
	us-gaap	Payments For Proceeds From Hedge Financing Activities PaymentsForProceedsFromHedgeFinancingActivities	-14000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	300000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	600000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	14000000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	386000000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	435000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	10000000	USD
	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	12000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3383000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	113000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	284000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	293000000	USD
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	37000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	49000000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	34000000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	25000000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	386000000	USD
	us-gaap	Profit Loss ProfitLoss	1096000000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	382000000	USD
	us-gaap	Profit Loss ProfitLoss	1016000000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1796000000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1849000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	51000000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	46000000	USD
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	7405000000	USD
CY2017Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	7505000000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-3000000	USD
CY2016Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	117000000	USD
CY2017Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	117000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	60000000	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	6000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	19000000	USD
CY2017Q1	us-gaap	Restructuring Charges RestructuringCharges	15000000	USD
	us-gaap	Restructuring Charges RestructuringCharges	31000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	23000000	USD
CY2016Q2	us-gaap	Restructuring Reserve RestructuringReserve	16000000	USD
CY2017Q1	us-gaap	Restructuring Reserve RestructuringReserve	25000000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6419000000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4842000000	USD
CY2016Q1	us-gaap	Revenues Revenues	30662000000	USD
	us-gaap	Revenues Revenues	90162000000	USD
CY2017Q1	us-gaap	Revenues Revenues	31821000000	USD
	us-gaap	Revenues Revenues	97010000000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	914000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2678000000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	960000000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2792000000	USD
CY2016Q1	us-gaap	Severance Costs1 SeveranceCosts1	6000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	11000000	USD
CY2017Q1	us-gaap	Severance Costs1 SeveranceCosts1	14000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	27000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	82000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	73000000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4000000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.28
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1000000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7000000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7000000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	54.09
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.99
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	37.46
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.11
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000000	shares
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	6554000000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	6646000000	USD
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6571000000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6665000000	USD
CY2016Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	42000000	shares
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	11000000	shares
	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	37000000	shares
CY2016Q2	us-gaap	Treasury Stock Value TreasuryStockValue	2759000000	USD
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	744000000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	394000000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	145000000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	105000000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	355000000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	258000000	USD
CY2016Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2017Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	331000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	331000000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	318000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	320000000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	328000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	328000000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	316000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	318000000	shares

Files In Submission

Name	View Source	Status
0000721371-17-000031-index-headers.html	Edgar Link	pending
0000721371-17-000031-index.html	Edgar Link	pending
0000721371-17-000031.txt	Edgar Link	pending
0000721371-17-000031-xbrl.zip	Edgar Link	pending
a17q3_10qx033117xexhibit121.htm	Edgar Link	pending
a17q3_10qx033117xexhibit311.htm	Edgar Link	pending
a17q3_10qx033117xexhibit312.htm	Edgar Link	pending
a17q3_10qx033117xexhibit321.htm	Edgar Link	pending
a17q3_10qx033117xexhibit991.htm	Edgar Link	pending
a17q3_10qx033117xform10-q.htm	Edgar Link	pending
a17q3_10qx033xchart-25924.jpg	Edgar Link	pending
a17q3_10qx033xchart-25989.jpg	Edgar Link	pending
a17q3_10qx033xchart-26782.jpg	Edgar Link	pending
a17q3_10qx033xchart-26986.jpg	Edgar Link	pending
a17q3_10qx033xchart-27540.jpg	Edgar Link	pending
a17q3_10qx033xchart-28129.jpg	Edgar Link	pending
a17q3_10qx033xchart-28259.jpg	Edgar Link	pending
a17q3_10qx033xchart-28895.jpg	Edgar Link	pending
a17q3_10qx033xchart-29037.jpg	Edgar Link	pending
a17q3_10qx033xchart-29732.jpg	Edgar Link	pending
a17q3_10qx033xchart-30019.jpg	Edgar Link	pending
a17q3_10qx33117xexhibit102.htm	Edgar Link	pending
cah-20170331.xml	Edgar Link	completed
cah-20170331.xsd	Edgar Link	pending
cah-20170331_cal.xml	Edgar Link	unprocessable
cah-20170331_def.xml	Edgar Link	unprocessable
cah-20170331_lab.xml	Edgar Link	unprocessable
cah-20170331_pre.xml	Edgar Link	unprocessable
cah033117form10q.pdf	Edgar Link	pending
cvrpic63016a01a02a08.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2017 Q2 Form 10-Q Financial Statement

#000072137117000031 Filed on May 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2017 Q2 Form 10-Q Financial Statement

#000072137117000031 Filed on May 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah